• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
  • Log In
    • Register
Contacts us @ MediPr.org
Medical News Asia | Powered by ['mediPr]
  • MDnews
  • About [‘mediPr]
  • HER2 Explorer
  • TROP Tool
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
PR-PIE-2022400-mCRC-Highlight

Therapeutic Advances in BRAFV600E-mutant mCRC

3 November 2023/Enter your password to view comments./in Therapeutic Areas, Oncology/by Connie TANG

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2023/11/MPR-PIE-2022400-mCRC-Highlight-WEB-07.jpg 1080 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-11-03 14:32:172023-11-03 18:18:07Therapeutic Advances in BRAFV600E-mutant mCRC
Advancement in mCRC Management: 2022 Review

Advancement in mCRC Management: 2022 Review

31 July 2023/Enter your password to view comments./in Oncology/by Jeffrey Martin

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2023/07/MPR-MER-2022083-Erbitux-Webinar-Highlight_part-3-WEB-07-1.jpg 1024 1918 Jeffrey Martin https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Jeffrey Martin2023-07-31 11:54:512023-08-03 09:54:13Advancement in mCRC Management: 2022 Review
MPR-ZUE-2022229 - Zuellig PBM Highlight

Concept and clinical evidence of patient blood management

14 June 2023/Enter your password to view comments./in Haematology, Oncology/by Kathlin Ambrose

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2023/06/MPR-ZUE-2022229-Zuellig-PBM-Highlight-scaled.jpg 1367 2560 Kathlin Ambrose https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kathlin Ambrose2023-06-14 17:00:162023-06-16 12:28:58Concept and clinical evidence of patient blood management
New Paradigms in the Multidisciplinary Management of Locally Advanced Rectal Cancer

New Paradigms in the Multidisciplinary Management of Locally Advanced Rectal Cancer

5 May 2023/Enter your password to view comments./in Oncology/by Coco Chong

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2023/05/New-Paradigms-in-the-Multidisciplinary-Management-of-Locally-Advanced-Rectal-Cancer-scaled.jpg 1367 2560 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2023-05-05 16:50:532023-05-22 11:10:18New Paradigms in the Multidisciplinary Management of Locally Advanced Rectal Cancer
MPR-BAY-2022196 How novel hormonal agents are changing treatment paradigms in advanced prostate cancer

How novel hormonal agents are changing treatment paradigms in advanced prostate cancer

9 March 2023/Enter your password to view comments./in Oncology/by Anne Michael

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2023/03/MPR-BAY-2022196-How-novel-hormonal-agents-are-changing-treatment-paradigms-in-advanced-prostate-cancer.png 2134 3996 Anne Michael https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Anne Michael2023-03-09 11:55:402023-05-16 11:39:11How novel hormonal agents are changing treatment paradigms in advanced prostate cancer

Clinical application of ctDNA in guiding anti-EGFR therapy in the treatment of metastatic colorectal cancer

7 March 2023/Enter your password to view comments./in Oncology/by Coco Chong

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2023/03/Clinical-application-of-ctDNA-in-guiding-anti-EGFR-therapy-in-the-treatment-of-metastatic-colorectal-cancer-scaled.jpg 1366 2560 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2023-03-07 12:15:032023-03-21 15:40:58Clinical application of ctDNA in guiding anti-EGFR therapy in the treatment of metastatic colorectal cancer
MPR-MER-2022093 Tepmetko Highlight

Therapeutic advances in non-small cell lung cancer with met exon 14 skipping alterations

11 January 2023/Enter your password to view comments./in Lung Cancer, Oncology/by Coco Chong

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2023/01/MPR-MER-2022093-Tepmetko-Highlight.png 502 4000 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2023-01-11 10:46:142023-03-08 12:43:45Therapeutic advances in non-small cell lung cancer with met exon 14 skipping alterations
Protection is Never Premature_Maternal COVID-19 Infection and Adverse Perinatal Outcomes

Protection is Never Premature: Maternal COVID-19 Infection is Associated with Adverse Perinatal Outcomes

5 December 2022/0 Comments/in COVID-19, SARS-CoV2, Infectious Disease, Paediatric/by Christy Leung

Pregnancy can be divided into three trimesters, corresponding to different stages of foetal development — the first trimester (Weeks 0 to 13+6) is characterised by foetal organ growth including neurodevelopment and craniofacial development; developed organs gain functionality during the second trimester (Weeks 14 to 26+6) and the foetus grows further and prepares for viability at the third trimester (Weeks 27 to 40+6).

Read more
https://medi-paper.com/wp-content/uploads/2022/12/Protection-is-Never-Premature_Maternal-COVID-19-Infection-and-Adverse-Perinatal-Outcomes.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-12-05 11:58:442023-03-08 12:42:36Protection is Never Premature: Maternal COVID-19 Infection is Associated with Adverse Perinatal Outcomes
Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents

Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents

7 November 2022/Enter your password to view comments./in COVID-19, SARS-CoV2, Infectious Disease, Paediatric/by Connie TANG

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2022/11/Should-your-child-receive-covid-19-vaccination.-Risk-benefit-analyses-in-infants-children-and-adolescents.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-11-07 02:14:052022-11-09 03:12:41Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents
Upfront Treatment of Advanced Stage Follicular Lymphoma - A Case Study of Obinutuzumab in Hong Kong

Upfront Treatment of Advanced Stage Follicular Lymphoma – A Case Study of Obinutuzumab in Hong Kong

20 October 2022/Enter your password to view comments./in Haematology/by Stijn van den Borne, MSc

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2022/10/Upfront-Treatment-of-Advanced-Stage-Follicular-Lymphoma-A-Case-Study-of-Obinutuzumab-in-Hong-Kong.png 2135 3997 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2022-10-20 03:59:502022-10-21 04:35:04Upfront Treatment of Advanced Stage Follicular Lymphoma – A Case Study of Obinutuzumab in Hong Kong
Page 3 of 22‹12345›»

Categories

Categories

Newsletter


 [‘mediPr] | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | CORTiX AI for Medical Science | Dub-Dub Subtitle Generation
© 2016-2026 MediPaper Medical Communications Ltd. | Website by [’mediPr] Sydney | Singapore | Hong Kong | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
Scroll to top Scroll to top Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings×

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

5
Accept settingsHide notification only